- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01175421
Multidimensional System as Predictor of Outcomes in Obstructive Sleep Apnea: The OSA-SCORE (OSA-SCORE)
March 19, 2015 updated by: Jose M. Marin, Hospital Miguel Servet
Development and Validation of a Multidimensional System as Predictor of Outcomes in Obstructive Sleep Apnea: The OSA-SCORE
Purpose:
In a retrospective cohort the investigators will validate, the goodness of a multidimensional index to classified the severity of patients with sleep disordered breathing that has been previously developed in a prospective longitudinal cohort.
Study Overview
Status
Completed
Conditions
Detailed Description
Methods.
In the developing study, three variables were found as predictors of mayor outcomes and were incorporated in a multidimensional index: the apnea-hypopnea index, the severity of daytime sleepiness as quantified by the Epworth questionnaire and the presence of current cardiovascular disease.
The index (OSA-SCORE) has a value between 0 (less risk) to 5 (more risk).
For each point, a significant increment in the risk of death was found.
In the retrospective validation study, a number of potential variables will be recorded, all of them also predictors of major outcomes.
Data will be recorded by trained personnel on-site at the respiratory Sleep Units around the country.
The final cohort will include 1100 subjects aged > 18 years .
The observation time will be considered since the time at diagnosis to fatal event and the patient will be censored when non-invasive ventilation was started or at the recorded time if the patient is alive.
The primary outcome is all-cause death.
Study Type
Observational
Enrollment (Actual)
1100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Zaragoza, Spain, 50190
- Hospital Universitario Miguel Servet
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Sleep Clinic
Description
Inclusion Criteria:
- Adults patients (> 18 years)
Exclusion Criteria:
- Under 18 years old
- Unable to complete sleep study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Patients undergoing sleep study
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
All cause mortality
Time Frame: Five years
|
Five years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Cardiovascular events
Time Frame: Five years
|
Five years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jose M Marin, M.D., Hospital Miguel Servet
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2010
Primary Completion (Actual)
May 1, 2013
Study Completion (Actual)
May 1, 2013
Study Registration Dates
First Submitted
August 3, 2010
First Submitted That Met QC Criteria
August 3, 2010
First Posted (Estimate)
August 4, 2010
Study Record Updates
Last Update Posted (Estimate)
March 23, 2015
Last Update Submitted That Met QC Criteria
March 19, 2015
Last Verified
August 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PS09/02449
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Snoring
-
Merz Pharmaceuticals GmbHTerminatedHabitual SnoringGermany
-
Johns Hopkins UniversityWithdrawn
-
Washington University School of MedicineRecruiting
-
Norton HealthcareDelta Dental FoundationRecruiting
-
VMS Medical Products, IncTerminated
-
Zelegent, Inc.CompletedSnoringUnited States
-
Brigham and Women's HospitalCompleted